You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 46 Efficacy of atezolizumab and docetaxel in patients with HER2-positive non-small cell lung cancer: a pooled post hoc of the OAK and POPLAR trials

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
46 Efficacy of atezolizumab and docetaxel in patients with HER2-positive non-small cell lung cancer: a pooled post hoc of the OAK and POPLAR trials

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 202317207
Dec 20234508
Jan 20242203
Feb 20244603
Mar 20243601
Apr 20243204
May 20242202
Jun 20241402
Jul 20241003
Aug 20241002
Sep 20241405
Oct 20243208
Nov 20242209
Dec 20241003
Jan 20252007
Feb 2025006
Mar 20250010
Apr 2025003
May 2025005
Jun 2025003
Total507094